GANIRELIX JUNO/ ARX GANIRELIX (Luminarie Pty Ltd)
Product name
GANIRELIX JUNO/ ARX GANIRELIX
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
98 (255 working days)
Active ingredients
ganirelix
Registration type
New generic medicine
Indication
For the prevention of premature luteinisation and ovulation in patients undergoing controlled ovarian stimulation, followed by oocyte pick up and assisted reproductive techniques.